Keywords: Liver, CancerQuantitative European Association for the Study of the Liver (qEASL) can better evaluate the therapeutic efficacy of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE). Conventional qEASL is often achieved semi-automatically, which is tedious, labor-intensive, and time-consuming. In this study, we provide and assess an automatic qEASL approach based on a VoxelMorph and Faster R-CNN framework named Shukun PortalDoc. We compared the consistency of the proposed method with the widely accepted semi-automatic software (MultiModality Tumor Tracking, Philips IntelliSpace Portal, Philips healthcare) in assessing qEASL of hepatocellular carcinoma after TACE.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords